AN2 Therapeutics (ANTX) Receivables - Accured (2022 - 2026)
AN2 Therapeutics (ANTX) posted Receivables - Accured of $300,000 for Q2 2026, down 25.0% from $400,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Receivables - Accured (2022 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics' Receivables - Accured came in at $400,000, up 33.3% from FY2024.
- Annual Receivables - Accured shows a three-year compound annual growth rate of 26.0% (FY2022 to FY2025).
- In prior years, AN2 Therapeutics' Receivables - Accured was $300,000 in FY2024 (-25.0%), $400,000 in FY2023 (+100.0%) and $200,000 in FY2022.
- Quarterly Receivables - Accured has run from a low of $200,000 in Q4 2022 to a high of $500,000 in Q3 2023 over five years.
- On a year-over-year basis, Receivables - Accured increased in three of the last eight quarters, with an average decline of 1.9%.
- The strongest year-over-year quarter for Receivables - Accured in the past five years was Q1 2024, with growth of 100.0%; the weakest was Q3 2024, with a decline of 40.0%.
- According to Business Quant data, Receivables - Accured for the three prior quarters was $300,000 (Q1 2026), $400,000 (Q4 2025) and $400,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | AN2 Therapeutics | 181.91 Mn | 181.91 Mn | - | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
API Access
AN2 Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();